MegaPro Biomedical Co., Ltd (TPEX:6827)
Taiwan · Delayed Price · Currency is TWD 10.00
-0.25 (-2.44%)
Aug 13, 2026, 11:29 AM CST
MegaPro Biomedical Market Cap
MegaPro Biomedical has a market cap or net worth of 663.39 million as of August 13, 2026. Its market cap has decreased by -43.06% in one year.
Market Cap
663.39M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
10.00
ChartMarket Cap Chart
Since October 19, 2021, MegaPro Biomedical's market cap has decreased from 2.11B to 663.39M, a decrease of -68.61%. That is a compound annual growth rate of -21.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 663.39M | -17.67% |
| Dec 31, 2025 | 805.78M | -14.43% |
| Dec 31, 2024 | 941.69M | -32.75% |
| Dec 29, 2023 | 1.40B | 24.04% |
| Dec 30, 2022 | 1.13B | -38.43% |
| Dec 30, 2021 | 1.83B | -13.24% |
| Oct 19, 2021 | 2.11B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GeneReach Biotechnology | 985.61M |
| Holy Stone Healthcare | 916.72M |
| TCI GENE | 899.59M |
| Meribank Biotech | 860.90M |
| Taiwan Advance Bio-Pharmaceutical | 813.60M |
| NatureWise Biotech & Medicals | 793.70M |
| BioLASCO Taiwan | 737.63M |
| Neith | 710.20M |